Skip to main content

SToP Anaphylaxis!


World Allergy Week 2021, hosted by the World Allergy Organization (WAO), presents "SToP Anaphylaxis!", a complimentary webinar for a general audience.

Thursday, 17 June 2021
8:00 am Eastern Time (New York)
Click for Time Zone Converter

Moderator: Prof. Michael Levin

Introduction by WAO President - Prof. Motohiro Ebisawa
Global Differences in Anaphylaxis - Prof. Margitta Worm
WAO Anaphylaxis Guidance - Prof. Victoria Cardona
Improving Global Access to Self-Injectable Epinephrine - Prof. Luciana Kase Tanno
Allergic Reactions to COVID-19 Vaccines -
Prof. Paul J. Turner

Anaphylaxis is a serious allergic reaction that comes on suddenly and severely after exposure to allergens, most commonly food, drugs, and insect venom, and can be fatal.

Anaphylaxis involves the airway, breathing, or circulation (ABC). Features of anaphylaxis include asthma-like symptoms, low blood pressure/fainting, confusion – usually in the context of more typical symptoms of a mild allergic reaction, such as hay fever-like symptoms, itchy skin rash (hives), swelling of the lips or face, abdominal pain or vomiting. Anaphylactic shock is the most severe presentation, in which insufficient blood is circulating around the body, resulting in collapse.

It is important to learn the early signs of anaphylaxis and be able to recognize it and respond quickly. Immediate injection of intramuscular epinephrine (adrenaline) at the first sign of anaphylaxis and calling for an ambulance is the most effective way to treat anaphylaxis. Epinephrine (adrenaline) is available as intramuscular auto-injectors or pre-filled syringes. However, not all parts of the world have epinephrine (adrenaline) for patients to keep as rescue medication. This is an unmet need that should be addressed.

People at risk of anaphylaxis should work with their allergy/immunology specialist to learn how and when to self-inject epinephrine (adrenaline), as well as to develop an emergency plan. They must carry both the medicine and plan with them at all times.


  • Motohiro Ebisawa, MD, PhD

    Sagamihara National Hospital
    Sagamihara, Kanagawa, Japan
    President, World Allergy Organization

  • Michael Levin, MD, PhD

    University of Cape Town
    Cape Town, South Africa

  • Margitta Worm, MD, PhD

    Berlin, Germany

  • Victoria Cardona, MD, PhD

    Hospital Vall d'Hebron
    Barcelona, Spain

  • Luciana Kase Tanno, MD, PhD

    University Hospital of Montpellier and
    Desbrest Institute of Epidemiology and Public Health
    INSERM, University of Montpellier
    Montpellier, France

  • Paul J. Turner, FRCPCH, PhD

    National Heart Lung Institute, Imperial College London, London, England
    School of Medicine, University of Sydney, Sydney, Australia

June 17, 2021
Thu 8:00 AM EDT

Duration 2H 0M

Already Registered?
For Technical Support
(888) 705-6002
+1 (858) 201-4136*
*for callers residing outside of the United States